PortfoliosLab logo

Aerovate Therapeutics, Inc. (AVTE)

Equity · Currency in USD · Last updated Jan 25, 2023

Company Info

ISINUS0080641071
CUSIP008064107
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$23.10
Year Range$8.64 - $30.52
EMA (50)$23.52
EMA (200)$18.59
Average Volume$149.92K
Market Capitalization$568.38M

AVTEShare Price Chart


Loading data...

AVTEPerformance

The chart shows the growth of $10,000 invested in Aerovate Therapeutics, Inc. in Jul 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $10,346 for a total return of roughly 3.46%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2023
13.51%
-1.36%
AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)

AVTECompare to other instruments

Search for stocks, ETFs, and funds to compare with AVTE

Aerovate Therapeutics, Inc.

AVTEReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD-19.39%4.62%
1M-15.37%4.48%
6M24.19%1.26%
1Y186.30%-8.66%
5Y2.20%-4.23%
10Y2.20%-4.23%

AVTEMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20220.25%-17.26%87.42%-30.44%-4.71%28.64%42.35%-10.88%-16.39%17.67%-3.43%55.52%
2021-43.71%33.00%22.76%-24.07%-13.94%-14.00%

AVTESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aerovate Therapeutics, Inc. Sharpe ratio is 1.97. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2023
1.97
-0.36
AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)

AVTEDividend History


Aerovate Therapeutics, Inc. doesn't pay dividends

AVTEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2023
-22.61%
-16.25%
AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)

AVTEWorst Drawdowns

The table below shows the maximum drawdowns of the Aerovate Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aerovate Therapeutics, Inc. is 63.86%, recorded on Jan 21, 2022. It took 131 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-63.86%Jul 1, 2021142Jan 21, 2022131Aug 1, 2022273
-42.73%Aug 15, 202229Sep 23, 202255Dec 12, 202284
-24.31%Dec 13, 202227Jan 23, 2023
-4.56%Aug 8, 20224Aug 11, 20221Aug 12, 20225

AVTEVolatility Chart

Current Aerovate Therapeutics, Inc. volatility is 65.77%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%AugustSeptemberOctoberNovemberDecember2023
65.77%
17.05%
AVTE (Aerovate Therapeutics, Inc.)
Benchmark (^GSPC)